IDEAS home Printed from https://ideas.repec.org/a/pkp/ijomah/v2y2015i4p62-69id2241.html
   My bibliography  Save this article

Correlation between Her2/Neu and Histopatholoical Finding among Sudanese Female Breast Cancer Patients

Author

Listed:
  • Riyadh Hamed
  • Ahmed Abdelbadie
  • Ihsan Osman
  • El khazin Eltayeb
  • Husam Eldein Omer

Abstract

Background: This study is one of very few studies which have investigated HER-2/neu expression and its correlation with histopathological finding. A total of 328 breast cancer tissue samples had been analyzed using immunohistochemical techniques. Objective: To compare the expression of tumor markers (HER-2/neu) with other prognostic parameters for mammary carcinomas. Results: Stage I- III B breast cancer HER-2/neu negative are (62%), whereas positive are (22%). Stage IV breast cancer HER-/neu negative are (4%), whereas positive are (3%). Recurrent breast cancer HER-2/neu negative are (3%) while positive are (5%).Stage I breast cancer HER-2/neu negative are (10%), whereas positive are (1%). Referring to stage II A, II B breast cancer HER-/neu negative are (59%), whereas positive are (16%). Stage III A, III B breast cancer HER-2/neu negative are (10%), while positive are (4%). HER-2/neu negative breast cancer Tumor size [le] 2 cm are (11%), while positive are (2%). HER-2/neu negative breast cancer Tumor size2-5 cm are (23%), whereas positive are (9%).HER-2/neu negative, Tumor size >5 cm are (26%), while positive are (29%). HER-2/neu negative breast cancer Nodal metastasis 0 are (5%), while positive are (2%). HER-2/neu negative Nodal metastasis1-9 are (16%), whereas positive are (19%). HER-2/neu negative breast cancer Nodal metastasis [ge] 10 are (28%), while positive are (30%). HER-2/neu negative histological subtype NIDC are (2%), whereas positive are (1%). HER-2/neu negative histological subtype IDC are (67%), while positive are (25%). HER-2/neu negative histological subtype ILC are (1%), whereas positive are (1%). Lastly, HER-2/neu negative with others histological subtype are (3%), whereas positive are (0%). HER-2/neu negative histological grade I are (6%), whereas positive are (2%). HER-2/neu negative histological grade II are (21%), while positive are (7%). Lastly, HER-2/neu negative histological grade II are (40%), whereas positive are (24%). HER-2/neu negative lympho-vascular invasion- are (71%), positive are (29%). HER-2/neu negative with lympho positive or vascular positive are (80%), While among positive are (16%). Conclusion: In this study population, the HER-2/neu expression its relation with histopathological finding determined.

Suggested Citation

  • Riyadh Hamed & Ahmed Abdelbadie & Ihsan Osman & El khazin Eltayeb & Husam Eldein Omer, 2015. "Correlation between Her2/Neu and Histopatholoical Finding among Sudanese Female Breast Cancer Patients," International Journal of Medical and Health Sciences Research, Conscientia Beam, vol. 2(4), pages 62-69.
    • Handle: RePEc:pkp:ijomah:v:2:y:2015:i:4:p:62-69:id:2241
    as

    Download full text from publisher

    File URL: https://archive.conscientiabeam.com/index.php/9/article/view/2241/3314
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pkp:ijomah:v:2:y:2015:i:4:p:62-69:id:2241. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dim Michael (email available below). General contact details of provider: https://archive.conscientiabeam.com/index.php/9/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.